This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignee: Chemical & Biopharmaceuticals Laboratories of Patras S.a.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Michail Ziovas: Innovator in Biologically Active Insulin Derivatives
Introduction
Michail Ziovas is a notable inventor based in Patras, Greece. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of insulin derivatives. His innovative work has the potential to impact diabetes treatment and management.
Latest Patents
Ziovas holds a patent for "Biologically active insulin derivatives." This invention involves a single chain insulin analog that includes the A-chain and B-chain of human or animal insulin, along with specific disulfide bonds and covalent links between amino acids. The patent outlines pharmaceutical compositions that utilize these insulin derivatives and their therapeutic applications.
Career Highlights
Throughout his career, Michail Ziovas has worked with the Chemical & Biopharmaceuticals Laboratories of Patras S.A. His expertise in biopharmaceuticals has positioned him as a key figure in the development of innovative insulin therapies.
Collaborations
Ziovas has collaborated with notable colleagues, including Kleomenis Barlos and Dimitrios Gatos. Their combined efforts have contributed to advancements in the field of insulin research and development.
Conclusion
Michail Ziovas is a pioneering inventor whose work on biologically active insulin derivatives showcases his commitment to improving healthcare solutions. His contributions are vital in the ongoing quest for effective diabetes treatments.